Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment

The Brief Psychiatric Rating Scale.

Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works

Research diagnoses for tardive dyskinesia.

Schooler, N. R., & Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040080014 · Cited by 951 · see citing works

Photometric Assay of Dopamine-β-Hydroxylase Activity in Human Blood

Nagatsu, T., & Udenfriend, S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.9.980 · Cited by 503 · see citing works

Neuroleptic-induced supersensitivity psychosis

(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1409 · Cited by 224 · see citing works

Withdrawal syndromes associated with antipsychotic drugs

Gárdos, G., Jo, C., & Tarsy, D. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1321 · Cited by 192 · see citing works

Time-Dependent Effects of Phenothiazines on Dopamine Turnover in Psychiatric Patients

Post, R. M., & Goodwin, F. K. (1975) · Science · doi:10.1126/science.1166321 · Cited by 131 · see citing works

Relapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing Medication

Prien, R. F., Cole, J. O., & Belkin§, N. F. (1969) · The British Journal of Psychiatry · doi:10.1192/bjp.115.523.679 · Cited by 111 · see citing works

Determination of nanogram amounts of homovanillic acid in the central nervous system with a rapid semiautomated fluorometric method

Westerink, B. H. C., & Korf, J. (1975) · Biochemical Medicine · doi:10.1016/0006-2944(75)90101-5 · Cited by 69 · see citing works

Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites

Cohen, B. M., Herschel, M., & Aoba, A. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90062-3 · Cited by 68 · see citing works

Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal

Zander, K. J., Fischer, B., Zimmer, R., & Ackenheil, M. (1981) · Psychopharmacology · doi:10.1007/bf00431099 · Cited by 61 · see citing works

Simultaneous radioenzymatic assay of catecholamines and dihydroxy-phenylacetic acid /DOPAC/; comparison of the effects of drugs on the tuberoinfundibular and striatal dopamine metabolism and on plasma prolactin level

Fekete, M. I. K., Kanyicska, B., & Herman, J. P. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90582-9 · Cited by 54 · see citing works

Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment

Bowers, M. B., & Heninger, G. R. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90030-5 · Cited by 54 · see citing works

Understanding and Treating Tardive Dyskinesia

Cohen, S. (1983) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1983.10471961 · Cited by 47 · see citing works

Incidence and Severity of Tardive Dyskinesia Increase With Age

Johnson, G. F. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040080012 · Cited by 39 · see citing works

A biochemical study of tardive dyskinesia in young male patients

Jeste, D. V., DeLisi, L. E., Zalcman, S. J., Wise, C. D., Phelps, B. H., Rosenblatt, J. E., Potkin, S. G., Bridge, T. P., & Wyatt, R. J. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90034-2 · Cited by 36 · see citing works

Normal prolactin responses in tardive dyskinesia

Asnis, G. M., Sachar, E. J., Langer, G., Halpern, F. S., & Fink, M. (1979) · Psychopharmacology · doi:10.1007/bf00428314 · Cited by 31 · see citing works

Elevated Cerebrospinal Fluid Noradrenaline in Tardive Dyskinesia

Jeste, D. V., Doongaji, D. R., & Linnoila, M. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.144.2.177 · Cited by 31 · see citing works

Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal

Kirch, D. G., Hattox, S. E., Bell, J., Murphy, R. C., & Freedman, R. (1983) · Psychiatry Research · doi:10.1016/0165-1781(83)90046-x · Cited by 25 · see citing works

Comparative analysis of indices of central dopaminergic functions in man

Bagdy, G., Arató, M., Baraczka, K., & Fekete, M. I. K. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90359-4 · Cited by 20 · see citing works

Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment

Bagdy, G., Per�nyi, A., Frecska, E., R�vai, K., Papp, Z., Fekete, M. I. K., & Arat�, M. (1985) · Psychopharmacology · doi:10.1007/bf00427323 · Cited by 19 · see citing works

Prolactin response in tardive dyskinesia.

Wolf, M. E., Bowie, L. J., Keener, S. L., & Mosnaim, A. D. (1982) · PubMed · Cited by 13 · see citing works

Changes in Extrapyramidal Symptoms Following Anticholinergic Drug Withdrawal

Perényi, A., Gárdos, G., Samu, I., Kallos, M., & Cole, J. O. (1983) · Clinical Neuropharmacology · doi:10.1097/00002826-198303000-00006 · Cited by 7 · see citing works

Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism

Arató, M., Bagdy, G., Perényi, A., & Béla, Á. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90007-6 · Cited by 5 · see citing works

[Withdrawal symptoms after abrupt removal of neuroleptics as criteria to their differentiation].

Battegay, R. (1966) · PubMed · Cited by 4 · see citing works

Does neuroleptic blocking of dopamine receptors continue after chronic treatment?

Belmaker, R. H., Dasberg, H. H., & Ebstein, R. P. (1980) · PubMed · Cited by 3 · see citing works

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse

Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157 · see citing works

Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia

Miller, R. J., & Chouinard, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90044-e · Cited by 133 · see citing works

Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods

Kinon, B. J., Jeste, D. V., Kollack‐Walker, S., Stauffer, V. L., & Liu‐Seifert, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.016 · Cited by 56 · see citing works

Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design

Dixon, L. B., Thaker, G. K., Conley, R. R., Ross, D. E., Cascella, N. G., & Tamminga, C. A. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90061-m · Cited by 38 · see citing works

Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia

Miller, D. D., Flaum, M. A., Arndt, S. V., Fleming, F. W., & Andreasen, N. C. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.31 · Cited by 32 · see citing works

Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation

Schultz, S. K., Miller, D. D., Arndt, S., Ziebell, S., Gupta, S., & Andreasen, N. C. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00082-8 · Cited by 29 · see citing works

Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics

Tani, H., Suzuki, T., Fleischhacker, W. W., Tomita, M., Mimura, M., & Uchida, H. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000959 · Cited by 16 · see citing works

Amisulpride withdrawal dyskinesia: a case report

Lo, Y.-C., & Peng, Y.-C. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0148-0 · Cited by 9 · see citing works

A New Look on an Old Issue: Comprehensive Review of Neurotransmitter Studies in Cerebrospinal Fluid of Patients with Schizophrenia and Antipsychotic Effect on Monoamine's Metabolism

Gasnier, M., Ellul, P., Plaze, M., & Abdel-Ahad, P. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.3.395 · Cited by 7 · see citing works

Medication-Free Minors With Schizophrenia

Cohen, D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.324 · Cited by 2 · see citing works

Relationship of symptomatology of schizophrenia and tardive dyskinesia

Perényi, A., Norman, T. R., & Burrows, G. D. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90036-8 · Cited by 2 · see citing works

Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal

Zander, K. J., Fischer, B., Zimmer, R., & Ackenheil, M. (1981) · Psychopharmacology · doi:10.1007/bf00431099 · Cited by 61 · see citing works

Prolactin shifts after neuroleptic withdrawal

Green, A. I., Faraone, S. V., & Brown, W. A. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90026-2 · Cited by 22 · see citing works

Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology

Naber, D., Albus, M., Bürke, H., Müller-Spahn, F., Münch, U., Reinertshofer, T., Wissmann, J., & Ackenheil, M. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90108-8 · Cited by 34 · see citing works

Psychopathologische Veränderungen bei chronisch schizophrenen Patienten nach Neuroleptikaentzug: Beziehungen zu therapeutischen, neuroendokrinen und computertomographischen Variablen

Albus, M., Naber, D., Ackenheil, M., Bürke, H., Müller-Spahn, F., Münch, U., Reinertshofer, T., Schmidt-Vanderheyden, W., Weber, G., & Wissmann, J. (1986) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1001845 · Cited by 2 · see citing works

Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment

Bagdy, G., Per�nyi, A., Frecska, E., R�vai, K., Papp, Z., Fekete, M. I. K., & Arat�, M. (1985) · Psychopharmacology · doi:10.1007/bf00427323 · Cited by 19 · see citing works